Fundraising Fox

Elevara

London, GB · Founded 2025 · 14 employees on LinkedIn · 3 known investors

Find your way into Elevara

Elevara Medicines is a clinical-stage biotech developing ELV001, a first-in-class once-daily oral CDK4/6 inhibitor that targets fibroblast-like synoviocytes as an add-on therapy for rheumatoid arthritis and other chronic inflammatory diseases. Its drug is designed to combine with existing DMARDs for patients who have an inadequate response to standard treatments like methotrexate and TNF inhibitors.

BiotechHealthtechMedical Devices

Founders & leadership

Elevara was founded in 2025 by Emma Tinsley.

ET
Emma TinsleyinFounder & former CEO (now Non-Executive Director)
MZ
Mai-Britt ZoccainCEO

Investors · 3

Monograph Capital Partners✓ verifiedLondon
Sofinnova Partners✓ verifiedParis · $540K – $27M
Forbion✓ verifiedNaarden

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Elevara raises $70M Series A to accelerate RA therapy ELV001 2025inforcapital.com · Oct 2025Elevara Medicines Raises $70M in Series A Fundingfinsmes.com · Oct 2025Elevara Medicines Secures Funding to Revolutionize RA Treatment - Investors Hangoutinvestorshangout.com · Oct 2025Elevara Medicines Raises $70 Million Series A to Advance Phase 2 Rheumatoid Arthritis Trial and Expand Pipeline - BioSpacebiospace.com · Oct 2025Elevara Medicines raises $70M Series A for RA Phase 2 trial — Sofinnova Partnerssofinnovapartners.com · Oct 2025British biotech emerges with $70M series A and midstage arthritis assetfiercebiotech.com · Oct 2025

Frequently asked questions

What does Elevara do?
Elevara Medicines is a clinical-stage biotech developing ELV001, a first-in-class once-daily oral CDK4/6 inhibitor that targets fibroblast-like synoviocytes as an add-on therapy for rheumatoid arthritis and other chronic inflammatory diseases. Its drug is designed to combine with existing DMARDs for patients who have an inadequate response to standard treatments like methotrexate and TNF inhibitors.
Who founded Elevara?
Elevara was founded by Emma Tinsley in 2025.
Who are Elevara's investors?
Elevara's investors include Monograph Capital Partners, Sofinnova Partners, Forbion.
Where is Elevara headquartered?
Elevara is headquartered in London, GB.